Thu, Nov 27, 2014, 5:54 AM EST - U.S. Markets closed for Thanksgiving Day

Recent

% | $
Quotes you view appear here for quick access.

Chiquita Brands International Inc. Message Board

macrocosmonaut 10 posts  |  Last Activity: Oct 22, 2014 1:54 PM Member since: Aug 30, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • The company remainy heavily undervalued with sight on their assets and future potential. The CEO has already developed the Canon Mine at Breakwater Resources.

    Breakwater has been bougth by Nystar with around 230 million US-Dollar.

    The stock of Breakwater has climbed from 0.20 $ per share to around a peak high at 35 USD within four years.

    The same is possible to Mineral Hill Industries within the next years. The low cost mine is able to generate significant value to share holders in future.

    Do your own due dilligence.

    M.

    Sentiment: Strong Buy

  • macrocosmonaut by macrocosmonaut Oct 22, 2014 1:47 PM Flag

    I am upgrading HEB from underperform to longterm outperform.

    This estimate on the basis of promising new development to combat viral diseases such as Ebola.

    Ebola is attacking human antiviral alpha-Interferon responce. The role of alpha interferon is crucial in order to combat Ebola infection.

    The Ro of Ebola Pandemic is between 1.7 and 2.2 - so one Ebola patient is infecting two new persons.

    This means that Ebola outbreak will spread around the planet within a few months. The USA has only 9 special beds fpr Ebola patients in the whole country at 4 hospitals in the whole country.

    This means - as soon as 9 patients has developed Ebola - the pandemic in the USA will run out of control and spread to million of people in the follow up.

    No vaccine will be available within the next 9-12 monts. I expect 2-5 million infeckions in the USA until spring.

    Alpha Interferon treatment will play an essential role to combat viral disease like Marburg, Ebola or other viral hemorraghis fever diseases.

    The Glycoprotein 40 (GP40) in combination with GP 1 and GP2 are inhibiting host antiviral response by alpha interferon. Adding Alpha interferon to infected Ebola patients is able to reduce the viral load and to increase survival rate in infected patients.

    Alpha Interferon play a crucial role in the innate immune response in first line immune response to viral agents like Ebola.

    So the Alpha Interferon therapy will lead to new therapeutic effects in Ebola diseases.

    Do your own due dilligence.

    M.

    Sentiment: Strong Buy

  • macrocosmonaut by macrocosmonaut Sep 30, 2014 4:49 PM Flag

    The current marcet cap is reflecting a strong and irrational undervaluation at RBI Energy - similar to PLUG Power at 2013.

    The current marcet cap is extremly low and RB Energy is a possible take over target with sight on their assets.

    Tesla for example could buy the company easily in ordert to support the Gigafactory of its Lithium portfolio.

    Do your own due dilligence.

    M.

    Sentiment: Strong Buy

  • Reply to

    PSDV - upgrade - new PT 8 USD

    by macrocosmonaut Sep 29, 2014 5:10 PM
    macrocosmonaut macrocosmonaut Sep 29, 2014 8:46 PM Flag

    You want to know who I am ?

    So let´s start 6 years ago at the beginning of this thread. When PSDV started trading in the USA and I made the first recommendations at this stock - and was alone on this thread in a market hammered to the bottom.

    It was the time, when the financial crisis reached its climax and I predicted a big future within 2 years to this stock - and the stock climbed from 0.60 USD above 6 USD within 2 years and tenfold its value for the first time.

    Then the first morons came to this board - and I said its time to take the profits. And I sold my PSDV shares and realized the profits. I warned at that time even the Alimera shareholdes that PSDV and ALIM are able to drop to 1 USD in the follow up. And now try to find out waht the PPS of PSDV and ALIM did later after the first rally phase ?

    Correct - PSDV dropped to 1 USD and ALIM lost 90 percent of its value.

    Now I am recommending PSDV again an increasing the Price target from 1 USD to 8 USD. This estimate is based on several circumstances. Morons are shorting now this stock - and these morons will pay the profits to longterm investors. 8 USD is the minimum price target - the stock can even hit 21-35 USD within two years, if ALIM is able to treat around 40 000 patients globally in a year - each injection with propably 12500 USD per dose.

    Now try to make a good caluculation and PSDV is getting 20 percent...

    8 USD is possible in midterm future. Stock is moving in an intact long set up.

    Further - I want to point out, if you have no clue about sciences, technicals and medicine and ophthalmology you should better shut up and keep calm.

    M.

    Sentiment: Hold

  • macrocosmonaut by macrocosmonaut Sep 29, 2014 5:10 PM Flag

    I am upgrading PSDV after the approval by the FDA from sell, to hold and I am increasing the price tartget to 8 USD per share.

    This estimate is based on the new developments of the past days and the possibility that the Iluvien sales are able to reach 500 Million USD annual sales by Alimera., if around 40 000 patients a year are treated with Iluvien in a global context.

    If Psivida is getting 20 percent of the revenues, this means around 100 Million USD per year to Psivida. In such a case the stock is undervalued.

    Discounting some risk of the future I am increasing the Price target on midterm view from 1 USD to 8 USD.

    Do your own due dilligence.

    M.

    Sentiment: Hold

  • LEXG share price has dropped from around 11 USD to 0.009 USD per share.

    While the stock was heavily overvalued at around 11 USD - now this stock is heavily undervalued from my point of view.

    From technical point of view the stock should be able to climb to the 0.25 and 0.50 USD range per share in future.

    Current market cap isn´t reflecting the potential of the Lithium claims of LEXG.

    Even the water and oil projects are interesting projects of LEXG.

    This stock has a technical exaggeration at the downside. Take a look at the volume signals.

    M.

    Sentiment: Strong Buy

  • macrocosmonaut macrocosmonaut Sep 18, 2014 12:15 PM Flag

    Thank you for the correction.

    Delisting process will start when the stock will below 1 USD within the next 30 days.

    However - tax selling and other effects like overvaluation as described yesterday are able to sent the stock price lower.

    I think yesterday was a so called decrease selling.

    The real sell of will come at aroun 0.13 USD from my point of view.

    I think this sell of will be combined with cash infusion and dilution and a reverse split.

    The company needs cash in order not to go bankrupt.

    IMO.

    Best regards.

    M.

    Sentiment: Sell

  • ONCY share price dropped today to new lows and generated new sell signals - non regarding short term bounce traders.

    The study results are disspointing and from my point of view the whole Reolysin technology is questionable.

    The company is burning millions of cash and has no commercial produkt. The equity is significant below current stock price and market cap.

    Delisting and a delisting notice is coming with high presumability within the next 10 days.

    If this will happen PPS per share will drop below 0.50 USD.

    Further the company has to raise cash in order to keep in good standing. If the company isn´t able to raise cash they will go bankrupt.

    So with sight in the high risk profile and current overvaluation I see a risk adjusted fair value at present at 0.13 USD per share.

    Do your own due dilligence and note - that if ONCY isn´t able to be NASDAQ compliant that only a reverse split is able to helb the company in order to avoid delisting.

    M.

    Sentiment: Sell

  • Today the stock has made a classical sell off on huge volume.

    The company is heavily undervalued at present and the bearish sentiment indicates that the price of the stock has bottomed today.

    In a longterm view and even near and midterm view the presumability is hight that the company will increase sharesholders value within the next years in significant manner.

    This stock is able to be a multibillion US Dollar stock within a fews years.

    Watch and learn.

    Shorting undervalued stocks at current levels is very risky.

    Chance/Risk proportion is favourable for long trades.

    Do your own due dilligence.

    M.

    Sentiment: Strong Buy

  • After a technical analysis of complex wave patterns I am recommending INTC as a strong sell.

    The first PT is 17 USD per share on midterm view. The Longterm PT is below 10 USD - at 4.xx USD per share.

    Do your own due dilligence.

    M.

    Sentiment: Strong Sell

CQB
14.47+0.02(+0.14%)Nov 26 4:01 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.